Harte Hanks Announces Expiration of "Go-Shop Period" and Designation of "Exempted Parties"
ACCESS Newswire (Tue, 15-Sep 9:19 AM ET)
Are CHMI, ARX, HHS Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 24-Aug 7:47 AM ET)
PRNewswire (Sun, 23-Aug 2:46 PM ET)
Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 17-Aug 10:10 PM ET)
PRNewswire (Fri, 14-Aug 4:48 PM ET)
HHS Faces Scrutiny Over Sale Terms as Investigation Questions Shareholder Value
Market Chameleon (Fri, 14-Aug 6:29 AM ET)
Business Wire (Fri, 14-Aug 10:10 AM ET)
Market Chameleon (Fri, 14-Aug 5:35 AM ET)
Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share
ACCESS Newswire (Fri, 14-Aug 8:30 AM ET)
Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks
Globe Newswire (Fri, 14-Aug 8:30 AM ET)
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Harte-Hanks trades on the NASDAQ stock market under the symbol HHS.
As of October 5, 2026, HHS stock price declined to $4.54 with 50,206 million shares trading.
HHS has a beta of 2.15, meaning it tends to be more sensitive to market movements. HHS has a correlation of 0.08 to the broad based SPY ETF.
HHS has a market cap of $33.84 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, HHS traded as high as $8.87 and as low as $2.00.
The top ETF exchange traded funds that HHS belongs to (by Net Assets): VTI, VXF, BUSM, DFAS, DFAT.
HHS has outperformed the market in the last year with a return of +23.7%, while the SPY ETF gained +16.9%. In the last 3 month period, HHS beat the market returning +101.8%, while SPY returned +4.3%. However, in the most recent 2 weeks HHS has underperformed the stock market by returning -1.1%, while SPY returned +1.7%.
HHS support price is $4.48 and resistance is $4.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HHS shares will trade within this expected range on the day.